This study investigates autophagy and UPS dysfunction in Angelman syndrome, revealing altered signaling pathways and protein accumulation.
Angelman Syndrome (AS) is a neurodevelopmental disorder caused by the deficiency of the UBE3A gene that for a E3 ligase protein part of the ubiquitin-proteasome system (UPS). Autophagy and UPS systems remove abnormal proteins, but any dysfunction in these processes can affect neuronal development and wellbeing. Herein, the involvement of the UPS/autophagy system in the regulation of intracellular signaling pathways related to toxic protein accumulation was investigated in cellular and mice AS models, silenced for UB3A (UB3A-). The main findings are as follows: i)autophagy markers were upregulated in UBE3A- cells respect to control cells; ii)a dysregulation of AKT/mTOR pathway, which is linked to autophagy/synaptic development, was evidenced in cellular and animal models of AS with respect to controls; iii) the ubiquitin ligase MDM2 was downregulated, and the tumor suppressor p53, normally inhibited by MDM2, enhanced its expression and transcriptional activity in UB3A-cells with respect to controls. Finally, UB3A-cells presented a significant alteration in the levels of β-amyloids with respect to control cells, and a reduction of α-synuclein levels, typical of neurodevelopmental disorder. Overall, these data suggest that AS models presented altered signaling pathway related to autophagy/UPS systems, potentially leading to the accumulation of toxic proteins that impact synaptic development.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: